ArticleBlood2009

Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.

Zhihong Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.